Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

OBJECTIVE: Our objective was to assess the cost effectiveness of apixaban versus edoxaban in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) in Spain. METHODS: We customized a Markov model with ten health states to estimate the lifetime economic and clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyagüez, Itziar, Suárez, Carmen, López-Sendón, José Luis, González-Juanatey, José Ramón, de Andrés-Nogales, Fernando, Suárez, Jorge, Polanco, Carlos, Soto, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426339/
https://www.ncbi.nlm.nih.gov/pubmed/31673882
http://dx.doi.org/10.1007/s41669-019-00186-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426339/
https://www.ncbi.nlm.nih.gov/pubmed/31673882
http://dx.doi.org/10.1007/s41669-019-00186-7

Ejemplares similares